Welgene Biotech

What Welgene Biotech does

Welgene Biotech is a privately held, for-profit biotechnology company founded in 2003 and headquartered in Taipei. The company operates with a small workforce in the 11-50 employee range and remains private with no disclosed public listing, parent company, or subsidiaries. Beyond its classification as a biotechnology firm, the available input data provides no substantive detail on its specific product lines, underlying platform technology, therapeutic or research focus, or proprietary capabilities.

The input does not disclose the company's business model, revenue mechanics, pricing structure, go-to-market motion, or customer segments. The primary web source consisted only of a website verification/loading page, which yielded no product, technology, customer, or corporate governance information. A financial table included in the input reports revenue and profitability figures in the trillions of dollars, which are internally implausible for a company of this size and headcount and are treated as unreliable rather than as evidence of actual scale.

In summary, the evidence supports only a high-level firmographic profile: a long-established (founded 2003), small, private Taipei-based biotechnology company. All deeper analytical dimensions — products, technology, moats, customers, and financials — are unsupported by the supplied data and should be treated as significant information gaps.

Name

Welgene Biotech

Website

https://welgene.com.tw

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Welgene Biotech is a privately held, small (11-50 employee) biotechnology company founded in 2003 and based in Taipei; the available data does not specify its products, technology, or customer base.

Ownership category

akta.pro rank

Product category

Biotechnology

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAHAA

Small-Molecule API Process Development & Route Scouting

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

• Biotechnology products
• Life sciences research
• Biological reagents
• Biomedical solutions
• Cell biology products

Headquarters

HQ city

Taipei

HQ country

China

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D

Core offering

Welgene Biotech operates as a biotechnology company. Based on the limited source material available, the company's website (welgene.com.tw) presented only a verification/loading page with no substantive product, service, or capability details exposed. The firmographic descriptor identifies Welgene Biotech as a biotechnology company headquartered in Taipei, founded in 2003, with 11-50 employees.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific is a global leader in cell culture media and bioprocessing products for the biopharmaceutical industry. It is the most direct comparable to a Taiwan-based cell culture media and life science tools company of Welgene's likely profile.
• Corning Life Sciences: Corning Life Sciences manufactures cell culture vessels, media, and related consumables for research and bioprocessing. Its product portfolio overlaps directly with the cell culture and life science tools focus typical of a small Taiwan-based biotech tools firm.

Broad incumbents

• Thermo Fisher Scientific (Gibco brand): Thermo Fisher's Gibco brand is the dominant global supplier of cell culture media, sera, and reagents. It serves the same biopharma and research customer base as a small media and cell culture tools provider like Welgene.
• Lonza Group: Lonza is a major global CDMO and supplier of cell culture media, cell lines, and bioprocessing services. It overlaps with Welgene's likely offerings across cell line development and media, while operating at vastly greater scale.
• Cytiva: Cytiva (formerly GE Healthcare Life Sciences) supplies bioprocessing equipment, cell culture media, and services for the biopharmaceutical industry. It competes in many of the same life science tools categories that a media-focused Taiwan firm would address.
• Merck KGaA (Life Science / MilliporeSigma): MilliporeSigma supplies bioprocessing tools, cell culture media, and lab consumables used in pharmaceutical and biotech manufacturing. It competes broadly with small life science tools providers in upstream bioprocessing inputs.
• Sartorius: Sartorius provides bioprocessing equipment, consumables, and services for the biopharmaceutical industry, including cell culture-related products. It serves the same bioproduction customers that a media and cell line tools company would target.

Emerging players

• GenScript: GenScript is a global biotech company offering gene synthesis, peptide synthesis, and cell line development services. Its cell line engineering and biology services overlap with the type of upstream bioprocessing services a small Asian life science tools firm would offer.
• Bio-Techne: Bio-Techne provides reagents, proteins, and cell culture products for life science research and bioprocessing. Its product categories in cell culture and biotech reagents overlap directly with those of a cell culture and life science tools provider.

Regional players

• Bioneer: Bioneer is a Korean biotech company specializing in molecular biology tools, cell culture media, and life science research products. As an APAC-based life science tools provider, it is a strong regional comparable to a Taipei-headquartered firm of similar size and scope.

Market position

Strengths3 records

Weaknesses3 records

Key risks4 records

Key highlights3 records

Customer concentration

• Facebookfacebook.com/welgenebio
• LinkedInlinkedin.com/company/welgene-inc-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Welgene Biotech